rHEALTH

rHEALTH is developing portable diagnostic systems for self-analysis of blood and vitals, advancing humanity through spaceflight diagnostics and health AI. The company's integrated system combines three products: the SKYE Sensor, a chest-affixed device that sends real-time vital signs data via Bluetooth; the rHEALTH Diagnostics device, which collects a single drop of blood in a consumable and uses microfluidic technology to perform dilution, mixing, and complete sample prep; and a Comprehensive Health Analysis System with app and cloud-based management of personal health data. rHEALTH's technology has been tested on-orbit with NASA, demonstrating successful operation as the most powerful bioanalyzer in space. The company has publications in Nature Communications and PLOS ONE, holds 20 issued and pending patents, and was a finalist in the $10 million Qualcomm Tricorder XPRIZE and grand prize winner of the $2.25 million Nokia Sensing XCHALLENGE. Founded in 2010 and headquartered in Bedford, Massachusetts, rHEALTH has raised $3 million in seed funding from NIH and USAGov. The company's devices are currently limited by FDA regulation for research or investigational purposes only, with terrestrial regulatory certifications in progress for Earth-based applications.